Julius Wehrle Selected Research

Residual Neoplasm

1/2022

Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julius Wehrle Research Topics

Disease

14	Neoplasms (Cancer) 03/2023 - 07/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2020 - 07/2013
2	Polycythemia Vera 11/2020 - 07/2013
2	Primary Myelofibrosis (Myelosclerosis) 11/2020 - 07/2013
2	Polycythemia (Erythrocytosis) 01/2016 - 05/2013
1	Autoimmune Diseases (Autoimmune Disease) 12/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Ambulatory Care Sensitive Conditions 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Synovial Sarcoma (Synovioma) 04/2022
1	Residual Neoplasm 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021
1	Essential Thrombocythemia 11/2020
1	Melanoma (Melanoma, Malignant) 11/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2017
1	Glioma (Gliomas) 11/2017
1	Reticulocytosis 01/2016
1	Herpes Zoster 01/2014
1	Thrombocytosis (Thrombocythemia) 05/2013
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2012

Drug/Important Bio-Agent (IBA)

5	Circulating Tumor DNAIBA 01/2023 - 08/2020
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 04/2022
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 05/2013
2	NF-E2 Transcription FactorIBA 01/2020 - 01/2012
1	Imatinib Mesylate (Gleevec)FDA Link 03/2023
1	NucleotidesIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020
1	Decitabine FDA Link 07/2020
1	Apolipoproteins E (ApoE)IBA 01/2018
1	GlobinsIBA 01/2016
1	IronIBA 01/2016
1	VimentinIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Cadherins (E-Cadherin)IBA 01/2014
1	ponatinibIBA 01/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 07/2013
1	CytokinesIBA 07/2013

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2018
1	Ambulatory Care (Outpatient Care) 01/2023
1	Radiotherapy 09/2022
1	Drug Therapy (Chemotherapy) 09/2022